255 related articles for article (PubMed ID: 37060567)
1. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract][Full Text] [Related]
2. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
3. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
4. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C
Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112
[TBL] [Abstract][Full Text] [Related]
5. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
[TBL] [Abstract][Full Text] [Related]
6. Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
[TBL] [Abstract][Full Text] [Related]
8. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation.
Fang C; Wang Z; Han C; Safgren SL; Helmin KA; Adelman ER; Serafin V; Basso G; Eagen KP; Gaspar-Maia A; Figueroa ME; Singer BD; Ratan A; Ntziachristos P; Zang C
Genome Biol; 2020 Sep; 21(1):247. PubMed ID: 32933554
[TBL] [Abstract][Full Text] [Related]
9. Tandem CTCF sites function as insulators to balance spatial chromatin contacts and topological enhancer-promoter selection.
Jia Z; Li J; Ge X; Wu Y; Guo Y; Wu Q
Genome Biol; 2020 Mar; 21(1):75. PubMed ID: 32293525
[TBL] [Abstract][Full Text] [Related]
10. Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.
Pentland I; Campos-León K; Cotic M; Davies KJ; Wood CD; Groves IJ; Burley M; Coleman N; Stockton JD; Noyvert B; Beggs AD; West MJ; Roberts S; Parish JL
PLoS Biol; 2018 Oct; 16(10):e2005752. PubMed ID: 30359362
[TBL] [Abstract][Full Text] [Related]
11. CTCF shapes chromatin structure and gene expression in health and disease.
Dehingia B; Milewska M; Janowski M; Pękowska A
EMBO Rep; 2022 Sep; 23(9):e55146. PubMed ID: 35993175
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
13. CTCF mediates dosage- and sequence-context-dependent transcriptional insulation by forming local chromatin domains.
Huang H; Zhu Q; Jussila A; Han Y; Bintu B; Kern C; Conte M; Zhang Y; Bianco S; Chiariello AM; Yu M; Hu R; Tastemel M; Juric I; Hu M; Nicodemi M; Zhuang X; Ren B
Nat Genet; 2021 Jul; 53(7):1064-1074. PubMed ID: 34002095
[TBL] [Abstract][Full Text] [Related]
14. CTCF functions as an insulator for somatic genes and a chromatin remodeler for pluripotency genes during reprogramming.
Song Y; Liang Z; Zhang J; Hu G; Wang J; Li Y; Guo R; Dong X; Babarinde IA; Ping W; Sheng YL; Li H; Chen Z; Gao M; Chen Y; Shan G; Zhang MQ; Hutchins AP; Fu XD; Yao H
Cell Rep; 2022 Apr; 39(1):110626. PubMed ID: 35385732
[TBL] [Abstract][Full Text] [Related]
15. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
[TBL] [Abstract][Full Text] [Related]
16. Loop competition and extrusion model predicts CTCF interaction specificity.
Xi W; Beer MA
Nat Commun; 2021 Feb; 12(1):1046. PubMed ID: 33594051
[TBL] [Abstract][Full Text] [Related]
17. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
18. Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation.
Kim KL; Rahme GJ; Goel VY; El Farran CA; Hansen AS; Bernstein BE
Mol Cell; 2024 Apr; 84(7):1365-1376.e7. PubMed ID: 38452764
[TBL] [Abstract][Full Text] [Related]
19. Outward-oriented sites within clustered CTCF boundaries are key for intra-TAD chromatin interactions and gene regulation.
Ge X; Huang H; Han K; Xu W; Wang Z; Wu Q
Nat Commun; 2023 Dec; 14(1):8101. PubMed ID: 38062010
[TBL] [Abstract][Full Text] [Related]
20. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
